Mechanisms of antihyperglycaemic action of efaroxan in mice: time for reappraisal of α2A-adrenergic antagonism in the treatment of type 2 diabetes?
Titel:
Mechanisms of antihyperglycaemic action of efaroxan in mice: time for reappraisal of α2A-adrenergic antagonism in the treatment of type 2 diabetes?
Auteur:
Lehner, Z. Stadlbauer, K. Adorjan, I. Rustenbeck, I. Belz, M. Fenzl, A. Cillia, V. A. M. de Gruber, D. Bauer, L. Frobel, K. Brunmair, B. Luger, A. Fürnsinn, C.